This review investigates some key aspects of transport mechanisms and recent advances in our understanding of this ubiquitous cellular process. The prevailing model of cotransport is the alternating access model, which suggests that large conformational changes in the transporter protein accompany cotransport. This model rests on decades of research and has received substantial support because many transporter characteristics are explained using its premises. New experiments, however, have revealed the existence of channels in transporters, an idea that is in conflict with traditional models. The alternating access model is the subject of previous detailed reviews. Here we concentrate on the relatively recent data that document primarily the channel properties of transporters. In some cases, namely, the observation of single-transporter currents, the evidence is direct. In other cases the evidence-for example, from fluctuation analysis or transporter currents too large to be described as anything other than channel-like-is indirect. Although the existence of channels in transporters is not in doubt, we are far from understanding the significance of this property. In the online Supplemental Material, we review some pertinent aspects of ion channel theory and cotransport physiology to provide background for the channels and transporters presented here. We discuss the existence of channels in transporters, and we speculate on the biological significance of this newly unveiled property of transport proteins.
INTRODUCTION
Cotransporters employ the electrochemical gradient of certain ions to concentrate specific substrates. Since the early 1990s, new data from fluorescence microscopy and electrophysiology have suggested that conformational changes predicted by the alternating access model (1) of cotransport (see also Supplemental Figure 3 ) may be smaller than predicted and more similar to channel gating (1) (2) (3) (4) (5) . One of the most astonishing experiments of the new era of channel and transporter characterization is a study of pre-and postsynaptic signaling at an intact synapse (6) . Figure 1 shows a salient feature of this experiment. Figure 1 shows the pre-and postsynaptic responses to the release of serotonin [5-hydroxytryptamine (5-HT)] in a leech synapse under voltage clamp. Before the 5-HT-gated, postsynaptic receptor current occurs, a larger and faster presynaptic current, associated entirely with the serotonin transporter (SERT), occurs. This latter current is associated with transporting 5-HT back into the presynaptic terminal (uptake). Thus, as early as 1993, we had a strong indication Pre-and postsynaptic responses in a serotonergic synapse. Only a submillisecond delay occurs between a presynaptic Ca 2+ flash (arrow) and presynaptic serotonin uptake current, which is faster and larger than the serotonin-induced postsynaptic current (PSC). Pre-and postneurons were voltage clamped at −70 mV and −60 mV, respectively. From Reference 6.
that transporter currents can be as large as channel currents. Although this does not in itself define channel-like activity within a transporter, traditional models for cotransport predict less than 1 pA of uptake current for a million transporters operating at once. Thus, some activity extraneous to conventional explanations must be occurring. One outstanding question might be to what extent the uptake current is actually carried by the substrate (in this case, 5-HT + ) in addition to other ions. We discuss the details surrounding this question in the Supplemental Text, Section B3 (follow the Supplemental Material link from the Annual Reviews home page at http://www.annualreviews.org).
The point to note from Figure 1 is that in real synapses large currents are associated with neurotransmitter transporters. In this review, we consider carefully what purpose these presynaptic currents serve and whether they can be explained by traditional models with fixed stoichiometry and tight coupling or whether they require new models with channel-like properties.
CHANNELS IN TRANSPORTERS
Na + /K + ATPase Transport pumps are bonafide enzymes, and the prime example is Na + /K + ATPase (the Na + pump). For supporting details, please see the Supplemental Text (Section B2) and also References 7 and 8. Even the archetypical Na + pump, however, appears to become an ion channel under certain conditions. Palytoxin (PTX), a marine toxin, is found in reef corals that are armed with a stinging apparatus (9) . PTX depolarizes cells via nonselective cation channels of 10 pS (10) . Na + /K + ATPase is known to be the target because pump-specific oubaine antagonizes PTX (11) . PTX, which forms ion channels in the pump (Figure 2) , presumably binds the Na + pump, forming a pore coincident with the Na + /K + pathway, and activates a conductance with an affinity for Na + > K + . Oubaine accelerates (12, 13) and Hilgemann and colleagues (14) (15) (16) .
PTX washing-out effects, and preincubating the ATPase with the steroid slows subsequent activation of the PTX-induced conductance. Thus, PTX and ouabain likely occupy the Na + pump simultaneously, each destabilizing the other. PTX-induced channels are also permeable to large organic cations, including NMDG (N-methyl-d-glucamine), suggesting that the narrowest section of the pore must be at least 7.5Å wide.
Na + /Ca 2+ Exchangers
The Na + /Ca 2+ exchangers (NCXs) are a ubiquitously expressed group of transporters. They transport Ca 2+ across membranes against the ion's electrochemical gradient by using the electrochemical gradient of Na + . The cotransport is therefore bidirectional and is controlled by membrane potential and by both Na + and Ca 2+ (substrate) gradients. In cardiac muscle, exchangers extrude intracellular Ca 2+ during the excitation-contraction cycle. The stoichiometry for the exchange is thought to be 1 Ca 2+ :3 Na + ; hence, the exchanger is electrogenic, and membrane current is a quantitative readout of NCX activity (17) . Intracellular Ca 2+ concentration also assesses NCX function (18) . In cardiac myocytes, NCX is additionally crucial for Ca 2+ homeostasis and muscle relaxation after contraction and can play an important role in excitation-contraction coupling when running in reverse. During cardiac ischemia, malfunction of the exchanger causes Ca 2+ overload and cardiomyocyte dysfunction. Mammalian NCXs comprise a multigene family of homologous proteins with three isoforms: NCX1-3. NCX1 is expressed predominantly in the heart, kidney, and brain, whereas NCX2 and 3 are restricted primarily to skeletal muscle and brain. The three isoforms bear 70% identity to each other and have similar predicted membrane topologies, consisting of nine transmembrane domains (TMDs) and a large central cytoplasmic loop containing the exchanger inhibitory peptide (XIP) region, Ca 2+ -binding sites, and phosphoryla-tion sites. Another exchanger, NCKX2, is a Na + /Ca 2+ /K + exchanger.
As mentioned above, Ca 2+ import/export depends partly on the Na + :Ca 2+ exchange ratio or transport stoichiometry. Whereas Ca 2+ flux equilibrium experiments indicate Na + :Ca 2+ ratios of 3:1, reversal potential data suggest 4:1 ratios (16) . Using an ionselective electrode to quantify ion fluxes in giant patches, Hilgemann (19) showed that ion flux ratios during maximal transport in either direction are 3:2. Because Na + and Ca 2+ are present on both sides of the membrane, the net current and Ca 2+ flux additionally are dependent upon and can be reversed at different membrane potentials. Hilgemann proposes that transport of substrates by NCX1 is not restricted to a ratio of 3:1 but that other transport stoichiometries are indeed possible. These include 1:1 at a lower rate, a Na + -conducting mode that exports 1 Ca 2+ , and an electroneutral Ca 2+ influx mode that exports 3 Na + (Figure 3) . The two minor transport modes may potentially contribute to and determine resting concentrations of free Ca 2+ and background inward current in heart muscle (17, 20) . This release from strict substrate coupling ratios in NCX1 therefore shifts the definition of the mechanism involved in this molecule's function away from one that can be described wholly by the alternating access model and suggests characteristics more akin to those of channel proteins.
Noise analysis also suggests that NCX currents have a channel-like component (16) . NCX1 has a relatively high turnover rate at physiological membrane potentials, which, in terms of a unitary current, is on the order of 1 fA (6000 e sec −1 ). The channels, although not seen directly, are thought to fluctuate between open and closed states, similar to ion channels. The large transporter-associated currents observed therefore are somewhat expected, and net NCX1 currents in heart are comparable to the ion channel currents that comprise the cardiac action potential (Figure 4) .
Figure 3
Na + /Ca 2+ exchange model. (a) At one site, 2 Na + or 1 Ca 2+ bind, whereas only 1 Na + binds at the second site. When sites are occupied by 3 Na + or 1 Ca 2+ , ion translocation is fast (30,000 sec −1 ). Translocation of 1 Na + together with 1 Ca 2+ occurs ten times slower (2500 sec −1 ), and then Ca 2+ release rates are intermediate (10,000 sec −1 ). Three exchange modes are postulated. (b) NCX1 function in a resting myocyte. Ca 2+ import by the 2 Na + /1 Ca 2+ mode is balanced by Ca 2+ export in the 3 Na + / 1 Ca 2+ mode. Simultaneously, the Na + -conducting mode generates a background inward current. (c) Predicted voltage dependence of single-exchanger Ca 2+ flux and I(V) in the resting state of a cardiac myocyte. Positive y-axis values give inward Ca 2+ flux and outward cation flux rates. Relevant to cardiac physiology, the Na + /Ca 2+ transport ratio is approximately 4 in the negative potential range when free internal Ca 2+ rises to 2 mM. From Reference 17. 
Glutamate Transporters
Glutamate transporters belong to a class of membrane transporters known as excitatory amino acid transporters (EAATs) and are expressed in neurons and glial cells, where they limit extracellular glutamate concentrations. Climbing fiber Purkinje cell synapses in the cerebellum release glutamate that is rapidly bound by neuronal EAATs located postsynaptically. Photolysis of caged glutamate was used to characterize the current in Purkinje cells resistant to glutamate receptor antagonists and inhibited by the high-affinity EAAT antagonist TBOA (dl-threo-benzyloxyaspartic acid). Through the subtraction of this residual non-EAAT current from the response recorded in the absence of glutamate receptor antagonists, estimates of postsynaptic uptake were obtained. Analyses of such synaptic EAAT currents suggest that, on average, postsynaptic EAATs take up 1,300,000 glutamate molecules in response to a single climbing fiber action potential. Isolation of the synaptic EAAT current from the contaminating current suggests that, near physiological temperatures, only a small fraction of glutamate (∼1%) is removed postsynaptically (23) (24) (25) (26) . Additionally, EAATs exhibit an anion channel activity, which, although uncoupled from the glutamate transport mechanisms, is nevertheless gated by glutamate. The EAAT channel is Cl − selective, and activation of the EAAT Cl − channel alters synaptic currents more rapidly than Na + -coupled glutamate transport turnover (100 msec) could. Thus, charge movements in cotransporters, including those in this example of the glutamate transporter, are not always stoichiometrically coupled to neurotransmitter flux (see Supplemental Text, Sections B3 and B4). In voltage-clamped Xenopus laevis oocytes, in which it is possible to measure ion current and substrate flux simultaneously, charge-toflux ratios may vary from 1-2 to more than 100. Early studies of current fluctuations in photoreceptors (27) first hinted at the existence of the Cl − channel activity in the glutamate transporter. Heterologous expression of neurotransmitter transporters (28) made it possible to study their transport properties under controlled conditions. Characterization of their electrical properties eventually confirmed the presence of Cl − channels in glutamate transporters and showed that the transporter's channel kinetics were closely related to its glutamate transport kinetics (28, 29) . Amara, Kavanaugh, and colleagues (30) (31) (32) (33) have extensively studied EAATs and their dual channel-like and transporter-like properties.
The ion channel in the Na + -dependent glutamate transporter selects for Cl − , but glutamate transport is independent of Cl − . This is in marked contrast to the Na + /Cl −dependent monoamine transporters, in which function depends on both ions. The kinetics of the Cl − channel and the glutamate transporter are related. However, it is unknown whether mechanistically there are different pathways for the movement of glutamate and Cl − ions, or simply a single pore that can switch between two, sometimes separate, modes. Glutamate presumably does not permeate the Cl − channel activated during transport, and the coupling of glutamate to Na + , K + , and H + gradients is extremely tight (24) .
GLAST is the predominant glutamate transporter expressed in Bergmann glia (34) . In particular, the application of l-glutamate to outside-out patches pulled from cerebellar Bergmann glial cells activates EAAT transporter currents in less than 1 ms (35) (Figure 5 ). Glutamate released from climbing fibers likely escapes the synaptic cleft and reaches glial membranes shortly after its release.
The intrinsic kinetics of transporters from glial cells indicate that the glutamate concentration at glial cell membranes peaks at a lower level than the 1-3 mM in the synaptic cleft and likely persists extrasynaptically for up to 10 ms following release. Glutamate transporters expressed in glial cells have rapid kinetics and are capable of binding glutamate on a submillisecond timescale, similar to ionotropic glutamate receptors (37) . Rapid binding of glutamate provides an efficient mechanism for capturing the glutamate that escapes the cleft, reducing glutamate concentration and hence preventing elevated glutamate levels in the extracellular space. Glutamate transport, on the other hand, is much slower, on the order of 10 msec per transport cycle for the glutamate transporter (GLT-1) (30) (31) (32) . The exact mechanistic steps in the transport cycle that permit the channel mode and flow of anions are unknown.
Glucose Transporter
A new study by Naftalin and colleagues (38) uses a template model of the facilitated glucose transporter GLUT1 to reveal nine substrate-binding clusters spanning a hydrophilic channel through the transporter.
d-Glucose binds to five sites at the external opening, with increasing affinity as substrates approach the pore. The substrates then appear to pass through a narrow channel into an internal vestibule with four low-affinity sites. This channel view of molecular flux presents a very different picture of glucose transport than the alternating access model predicts. Contrast, for example, GLUT1 with the Na +coupled glucose transporter (SGLT1), which uses the transmembrane Na + gradient to concentrate glucose (39) (40) (41) (42) . The Na + -coupled glucose transporter itself, however, exhibits a proton channel behavior under some conditions (41) . Furthermore, electrophysiological characterization of another member of the same gene family, the human choline transporter (43) , reveals large nonstoichiometric currents (44) strongly suggestive of channellike properties.
Monoamine Transporters
An in-depth characterization of Na + /Cl −coupled neurotransmitter transporters has occurred since their early discovery by Axelrod and colleagues (45) . New research has revealed currents that obey electrodiffusion laws (please see Supplemental Text, Section A1). Single-transporter events have been observed in γ GABA (γ -aminobutyric acid) (46, 47) , NE (norepinephrine) (48), 5-HT (49), and DA (dopamine) (50) transporters. Largerthan-expected currents, as observed for the Na + /H + /K + -coupled glutamate transporters discussed above, are also encountered with the monoamine transporters. Single-channel or -transporter events, however, have not yet been observed in glutamate transporters. We therefore repeatedly observe that transporters can exhibit large currents and, in some cases, form observable channel-like pores that conduct both ions and substrates. These substrates may include the relatively large neurotransmitter molecules, which appear to permeate channel-like pores, at least for the monoamine transporters. For further theoretical discussion on this topic, please see Supplemental Text, Sections B3 and B4.
Investigators have thought for some time that a channel mode may exist for the Na + /Cl − -coupled transporters in the GAT/ NET gene family (51) (52) (53) (54) . In one mechanistic model, 5-HT and Na + permeate a narrow pore in SERT, and the experimentally measured coupling results from queuing of the copermeating species (55, 56) . Single-file diffusion of ions and substrate may account for transport against an electrochemical gradient and amplification of ion gradients into substrate gradients by raising the gradient ratio to a power (45, (56) (57) (58) ; see also Supplemental Text, Sections C3 and C4). This model of cotransport was inspired by Hodgkin & Keynes (59), who used a hypothetical singlefile, multi-ion pore model to explain their data. Numerous subsequent experiments also support the model (60). Hodgkin's autobiography (61) and the Supplemental Text, Sections A2 and B4, elaborate further on the single-file electrodiffusion model and its relevance to the present discussion of channel-like activities of transporters.
Serotonin transporters. SERT belongs to the GAT/NET family of cotransporters. SERT modulates serotonergic signaling in the central nervous system and is implicated in human mood and appetite behavior (62) . Serotonin-selective reuptake inhibitors block human SERT (hSERT) as well as 5-HT uptake and are used to treat depression and panic disorders (63, 64) . hSERT also functions as a receptor for methamphetamine (MDMA, or ecstasy), amphetamine (AMPH), and cocaine (65) . Like other Na + -coupled transporters, hSERT concentrates 5-HT against its gradient by using the energy stored in coupled ion gradients (4, 66) . SERTs expressed heterologously produce currents of magnitudes greatly in excess of those predicted by the alternating access model of cotransport. Interestingly, the observed currents are far more amenable to explanation by a channel model of transport (67, 68) . It is less clear, however, if the SERT-associated channel-type currents exist in native cells and have physiological significance. The data of Bruns et al. (6) (Figure 1) for the serotonin transporter compare well with the results presented in the section on glutamate transporters. Presynaptic uptake and the postsynaptic response to Ca 2+ uncaging both decay as single exponentials, with a strong correlation between the pre-and postsynaptic time constant. The response to a flash of Ca 2+ uncaging light demonstrated the faster activation of the presynaptic uptake current compared with the postsynaptic current. A delay of less than 1 ms was observed between flash and onset of the presynaptic uptake current. The presynaptic uptake current showed an initial fast decay followed by a slower decline that was paralleled by the decay of the postsynaptic current. Both components of the presynaptic current were strongly reduced in 5-mM Na + .
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DeFelice · Goswami In X. laevis oocytes expressing rat serotonin transporters, serotonin activates macroscopic currents that are at least 10 times larger than the flux of ( 3 H) serotonin. Furthermore, large serotonin-independent currents that were blocked by selective transporter blockers were also observed (69). Lin et al. (49) identified a point mutation in the serotonin transporter that increases the unitary conductance. Petersen & DeFelice (68) presented evidence that Drosophila SERT (dSERT) conducts not only Na + but also 5-HT + itself in a channel mode of conduction.
Quick (70) has shown that the SNARE protein syntaxin 1A (STX1A) binds the N-terminal domain of SERT and that this binding regulates two of the conducting states. STX1A binding abolishes the 5-HTinduced and leak currents. These two currents occur naturally in neurons, and they can cause endogenous depolarization of these cells. Hence, molecules that disrupt the SERT-STX1A interaction effectively influence neuronal excitability by regulating SERT activity (70) .
Norepinephrine transporters. Galli et al. (48, 71, 72) have performed several key experiments investigating the transport mechanisms of the norepinephrine transporters (NETs) (Figures 6 and 7) . In these studies, Galli et al. recorded currents in patches from NET-expressing cells while simultaneously monitoring NE flux. These authors observed that the neurotransmitter permeated the patches in discrete bursts that correlated with single-channel openings. Inorganic ions permeate the channel in addition to the neurotransmitter itself. One question these experiments raised was how NETs are able to concentrate NE against its electrochemical gradient if NE can permeate an open channel. The initial, large inward gradient of neurotransmitter transiently present in synapses just after NE release may be the driving force for clearance. When the extracellular concentration declines and the electrochemical gradient diminishes, another mechanism may take over. Additionally, single-file diffusion through the NE channel may help concentrate NE through the use of the Na + gradient (57, 58) .
Galli et al. (48, 71, 72) therefore demonstrate authentic channels in NETs. They also show bursts of NE release associated with discrete channel-opening events (Figure 7) . Dopamine transporters. Dopamine transporters (DATs) play a crucial role in the reuptake and release of neurotransmitters. Their mechanism of transport has classically been described using an alternating access model. Binding of DA and Na + and Cl − ions to an extracellularly oriented transporter is thought to induce a conformational rearrangement to an intracellularly oriented transporter from which the cargo is released into the cytosol, completing the transport process (73) (74) (75) . DA transport by DAT generates an electrical current because of the net movement of positive charge into the cell. DA efflux induced by the psychostimulant AMPH is believed to result from the ability of AMPH to reverse this inward transport process. Hence, the inward transport of AMPH by DAT increases the number of inward-facing transporter-binding sites and thereby increases the rate of outward DA transport through an exchange process. Curiously, however, there are modulators and mutations that differentially affect AMPH-induced DA efflux and uptake. For example, Khoshbouei et al. (74, 75) recently reported that N-terminal phosphorylation of human DAT (hDAT) plays a critical role in AMPH-induced DA efflux but not in DA uptake. These and other data suggest that the mechanism for the AMPH-induced DA efflux mediated by the reversal of DAT flux direction is more complex than a simple exchange process.
Cocaine, AMPH, and heroin elevate extracellular DA in the brain. Substrates like AMPH induce nonvesicular release of DA mediated by DAT. Outside-out patches from heterologous DAT-expressing cells or from dopaminergic neurons show that AMPH causes DAT-mediated DA efflux by a slow process consistent with an exchanger and a fast process of millisecond bursts of DA efflux through a channel in DAT. A single burst of DA is on par with the amount of DA released from a vesicle (76) . Such channel-like behavior associated with neurotransmitter efflux is also observed in the NETs.
Caenorhabditis elegans DA transporters (DAT-1) generate single-channel currents that are selective to Cl − ions (50). In 1-μM DA, small (−0.8 ± 0.1 pA) single-channel events were recorded (n = 7) at −120 mV (Figure 8) . These channels were abolished in 10-μM IMP (imipramine, a DAT-selective blocker) with 1-μM DA present. When external Na + was replaced by NMDG + , no IMP-sensitive events were recorded, and DAinduced, single-channel events were absent in patches pulled from dat-1-deleted dopaminergic neurons. Inhibitors that block DA receptors did not eliminate DA-induced channel events, whereas IMP blocked these currents. Furthermore, DAT-mediated macroscopic www.annualreviews.org • Transporters as Channels 97 and microscopic currents had a specific requirement for Na + and Cl − , a characteristic of the SLC6A family to which DAT-belongs. DA and AMPH increase the firing activity of rat dopaminergic neurons in culture, elicit inward currents primarily comprised of anions, and result in an excitatory response. In addition to clearing extracellular DA, currents associated with DAT therefore appear to modulate excitability and regulate neurotransmitter release from the dopaminergic midbrain neurons (77) .
Metal Ion Transporters
Exact cellular concentrations of metal ions are essential for the proper function of life processes. Disruption of normal, homeostatically controlled cellular concentrations of metal ions leads to cell disease and death either by starving the cell of a vital metabolic element or by causing irreversible cell damage through the generation of toxic metabolites. Metal ion homeostasis is therefore highly regulated and dependent on specific transporters, channels, and pore proteins that balance uptake, 98 DeFelice · Goswami storage, and secretion across cell membranes. Predominant disorders associated with metal ion overload or deficiencies include microcytic anemia, hereditary hemochromatosis, Menke's disease, Wilson's disease, and neurodegenerative diseases such as Alzheimer's and Parkinson's disease, Friedreich's ataxia, and pica.
Transition metal ions are essential for oxidative phosphorylation, DNA replication, neuronal signaling, oxygen carriage, muscle contraction, endocrine and exocrine secretion, and sensory transduction. The functional cloning and characterization of divalent cation transporter 1 [DCT1, also known as divalent metal ion transporter 1 (DMT1)], the rat homolog of mouse Nramp2 (natural resistance-associated macrophage protein 2) and human NRAMP2, were the first demonstration of an active cellular transport mechanism for divalent metal cations (e.g., Fe 2+ ) in mammalian cells (78) . DMT1 was isolated from an iron-deficient rat duodenal cDNA library, using a X. laevis oocyte expression cloning system. The library was screened by radiolabeled iron ( 55 Fe 2+ ) uptake activity in Xenopus ooctyes. Expression of DMT1 in oocytes stimulated greater-than-200-fold increases in 55 Fe 2+ uptake compared with control water-injected oocytes. Electrophysiological characterization using twomicroelectrode voltage-clamp analysis of injected ooctyes showed that the activity of the divalent cation transporter was electrogenic with reversible currents up to 1000 nA induced by 100-mM Fe 2+ at pH 5.5. The characterization also demonstrated that DMT1 transports a wide range of divalent cations such as Fe 2+ , Zn 2+ , Mn 2+ , Cu 2+ , Co 2+ , Cd 2+ , and Pb 2+ . The large Fe 2+ -induced, DMT1mediated currents were H + dependent; the size of the inward current was significantly enhanced when cells were shifted from an extracellular pH of 7.5 to 5.5. Steady-state Fe 2+ -evoked currents were saturable with Michaelis-Menten kinetics and affinity constants of 2 mM and 1-2 mM for Fe 2+ and H + , respectively, and showed a curvilinear volt-age dependence approaching a zero-current asymptote. Concomitant voltage-clamp and intracellular pH measurements showed that Fe 2+ uptake was accompanied by intracellular acidification, indicative of a symport mechanism of cotransport. This and subsequent studies therefore identified DMT1 as a bonafide transporter responsible for the H + -dependent cotransport of divalent metal cations across the plasma membrane of cells, including intestinal epithelial cells, and from the lumen of the early endosomal compartment into the cytoplasm.
Interestingly, however, in response to a decrease in extracellular pH, DMT1-injected oocytes demonstrated substantial inward currents compared with control ooctyes, even in the absence of divalent cation substrate. In addition to operating as an H + /divalent cation cotransporter, therefore, DMT1 appeared to exhibit an additional H + uniporter function, constituting the H + leak, as it has been termed, as this H + current is independent of the divalent cation transport pathway. A subsequent study by Chen et al. (79) further investigated this H + leak current (see Figure 9 ). Chen et al. simultaneously performed voltage-clamp analysis and radioisotope uptake measurements on DMT1injected oocytes in the presence of 10-mM 55 Fe 2+ and at a constant pH of 5.5. Calculation of the ratio of the total Fe 2+ -evoked current to the 55 Fe 2+ uptake showed that this ratio varied with membrane potential. At +10 mV, the charge-to-uptake ratio was close to 3:1, indicative of a cotransport stoichiometry of 1:1. At increasingly negative membrane potentials, however, the value of this ratio became unexpectedly high (20:1 at −80 mV), inconsistent with a 1:1 ratio for Fe 2+ and H + cotransport and favorable of a stoichiometryfree, uncoupled H + -mediated current. The charge-to-uptake ratios were apparently unaffected by the removal of extracellular Na 2+ , Ca 2+ , or Mg 2+ or the depletion of intracellular Cl − . The linear, nonsaturable kinetics of this uncoupled H + current suggested its conduction via a channel or pore-type mechanism Voltage dependence of the charge-to-Fe 2+uptake ratio of DMT1 mediated Fe 2+ transport. Fe 2+ -evoked currents and Fe 2+ uptake were measured simultaneously under voltage-clamp conditions. (a) Example of currents generated by 10-μM 55 Fe 2+ at 50 mV and pH 5.7. The charge moved was calculated by integrating the Fe 2+ -evoked current over the uptake period. (b) The charge moved at 50 mV was converted to pmol and plotted against Fe 2+ uptake. The slope of the linear fit, which is equal to the mean charge-to-uptake ratio, is 12.5 ± 0.5. (c) Dependence of charge to Fe 2+ uptake on the membrane voltage.
Figure from
Reference 79; see also Reference 80. and that the cotransport stoichiometry of H + and X 2+ (where X is a metal ion) is most likely variable and determined by [H + ] o :[H + ] i , as well as [X 2+ ] o :[X 2+ ] i , and more dependent on the first ratio. These findings add complexity to our picture of DMT1 as a transporter molecule, imparting to it a significant channel character.
The importance of iron as a biomolecule has led to extensive and multidisciplinary investigations of this interesting metal ion trans-porter. A recent study provides sufficient evidence for DMT1 as an example of transporters upon which this review concentrates (81) . In an attempt to reconfirm the transport characterization of an important diseaseassociated mutation, DMT1 G185R , that had previously been shown to abrogate the Fe 2+ transport function of DMT1, Xu et al. (81) unveiled that this single-nucleotide point mutation increased Ca 2+ permeability mediated by DMT1 in a channel-type pathway.
Previously, the initial characterization using Xenopus oocytes had shown that Ca 2+ was not a substrate for DMT1 transport. Ca 2+ did not mimic the effect of Fe 2+ in the evocation of inward currents. In fact, Ca 2+ present at 10-mM concentration produced only a small outward current at pH 5.5 and only partially inhibited Fe 2+ -evoked currents. Similarly, when cells expressing wild-type DMT1 were subjected to electrophysiological patch-clamp analyses, no significant current was detected in the presence of 10-mM Ca 2+ and 140-mM Na + at pH 7.4. However, in stark contrast, under the same conditions, cells expressing DMT1 G185R exhibited large, stable inward currents. These currents were inhibited by substitution of Ca 2+ and Na + in the extracellular medium with NMDG + . Unlike the X 2+ currents observed with wild-type DMT1, Ca 2+ currents mediated by DMT1 G185R were inhibited by a reduction of extracellular pH to 5.8. Transient kinetics of the Ca 2+ currents of the G185R mutant protein were distinct from those of the X 2+ currents mediated by wild-type DMT1, including fast voltage-dependent inactivation that was enhanced with increasing [Ca 2+ ] o . Cationic selectivity studies using DMT1 G185R showed that the permeability sequence of this channel (Ca 2+ > Sr 2+ > Ba 2+ > Li + > Na + > K + > Cs + ) was similar to L-type Ca 2+ channels. DMT1 G185R was, however, less selective for Ca 2+ than are other known voltage-gated channels. Additionally, its I(V) curve, kinetics, and sensitivity to pharmacological agents differed significantly in terms of mechanism from other known Ca 2+ channels, including the voltage-gated Ca 2+ channels, transient receptor proteins (TRPs), and Ca 2+ release-activated Ca 2+ channels. A biological purpose for the G185R gain-of-function mutation may be that elevated intracellular Ca 2+ concentrations increase uptake of nontransferrin-bound iron (81, 82) . Indeed, studies using reticulocytes from mice inherently carrying the G185R mutation (mk/mk) have shown that iron uptake in these cells represents 45% of that seen in wild-type cells, a value higher than that expected for a se-vere loss-of-function mutation. It is difficult at present, however, to speculate on the biological reason behind this phenomenon.
Another interesting discovery is associated with the electrophysiological characterization of the suppressor mitochondrial import function (SMF) proteins, SMF1, 2, and 3, which are yeast homologs of DMT1. These proteins bear 33-36% identity to DMT1 and 51-54% identity to each other. SMF1 expression is localized to the yeast plasma membrane, whereas SMF2 and SMF3 are mitochondrial membrane proteins. Complementation studies have demonstrated that SMF1 is a general metal ion transporter that transports a wide range of divalent metal cations, including Mn 2+ , Zn 2+ , Cu 2+ , Fe 2+ , Cd 2+ , Ni 2+ , and Co 2+ . SMF2 and 3 may be broad-range metal ion transporters that have specificity distinct from SMF1. Chen et al. (79) showed that SMF1 mediates Fe 2+ uptake in Xenopus oocytes in a H + -and voltage-dependent manner. Metal ion transport in SMF1 was electrogenic and saturable with Michaelis-Menten kinetics similar to DMT1. However, in contrast to DMT1, Na + inhibited divalent metal ion uptake by SMF1. Furthermore, in the absence of metal ions, Na + evoked large SMF1-specific inward currents at −50 mV. Both Fe 2+ and increased H + concentration inhibited this Na + current. The Na + currents were voltage dependent but exhibited neither saturation by hyperpolarization nor saturable Michaelis-Menten kinetics. Moreover, unlike the H + /Fe 2+ cotransport observed in SMF1, these Na + currents were susceptible to partial inhibition by Ca 2+ . Therefore, the Na + currents observed in SMF1 seem to be uncoupled to the H + /Fe 2+ cotransport. The Na + conduction pathway was nonselective to other monovalent ions, including Li + , K + , and Rb + , and mediated flux of Ca 2+ ions. Hence, metal ion transport in SMF1 (and possibly also SMF2) appears to have at least two main components: a proton-coupled divalent cation cotransport mechanism and an uncoupled channel-like pathway that mediates the permeation of Na + , other monovalent cations, and Ca 2+ . This double identity may be a signature of not only DMT1 and the SMF proteins but also other members of this family, such as the natural resistanceassociated macrophage protein 1 (Nramp1). Indeed, in the characterization of Nramp1 as a H + -coupled divalent cation antiporter, the large inward currents evoked by Fe 2+ were greater in amplitude than expected from 55 Fe 2+ radioisotope uptake measurements (83) .
Perhaps channel-like fluxes are integral to the mechanism of molecules identified essentially as transporters. Examples with relation to transition metal ion transport include members of both families of membrane proteins responsible for mammalian copper homeostasis: the P-type ATPase copper pumps and the CTR transporters. Active ClC-4, an extensively studied intracellular chloride channel, physically associates with and specifically modulates copper transport via the P-type ATPase copper pump ATP7B in hepatocytes (84) . Also, determination of the 6-Å projection structure of the copper uptake transporter CTR1 revealed the presence of a copper-permeable pore along the center threefold axis of the trimeric transporter complex, thus placing the structural design of this transporter in close proximity to that normally observed in channel proteins (85) .
A Cl − Channel Is Really a Cl − /H + Exchanger
Both structural and electrophysiological data are known for only one specific transporter, and the results are surprising. Accardi, Miller, and colleagues provide startling evidence that ClC-ec1, a membrane protein predicted by homology to be a Cl − channel, is actually a Cl − /H + countertransporter (86) (87) (88) . Their paper and associated commentary by Gadsby (89) challenge us to ask how transporters differ from ion channels and vice versa. Channels dissipate ion gradients by passive electrodiffusion. However, although ions predominantly move down their electro-chemical gradient, they may by chance move uphill. Thus, moment to moment, molecules may disobey thermodynamics, just as Boltzmann had described (90) , and this will apply to both channel and transporter mechanisms (see Supplemental Text, Section A2, and Supplemental Figure 1 ). Accardi & Miller bring out the salient features of the transporter-channel question in a powerful illustration that is strengthened greatly by the dual presence of structural and functional data (91, 92) .
If the signature of channels is allowing the downhill flux of ions (with the chance occurence of uphill flow), the signature of cotransporters is using this downhill energy to build other gradients (see Supplemental Text, Sections C1 and C2). These seemingly opposite characteristics led quite early to the failure of electrodiffusion as an adequate explanation for the mechanism for metabolite concentration (93) . Subsequently, the transport of molecules against their electrochemical gradients was more carefully explained mechanistically using an enzymatic theory with carrier kinetics developed by Jardetzky (94) in 1966 (see Supplemental Text, Section C3). Classically, cotransporters couple the electrochemical gradients of Na + or protons to the movement of other substrates; thus, they may be said to have both channel properties (ions flowing downhill) and transporter properties (substrates flowing uphill) (95) .
In the example of ClC-ec1, evidence for transporter properties comes from the observation that Cl − flux by this molecule in one direction is positively coupled with H + flux in the opposite direction (that is, antiport, exchange, or countertransport). Surely the ability of one ion to drive another in the opposite direction lies wholly within the domain of transporters. To examine this, we would need to know more about what countertransport means at both molecular and structural levels. Unfortunately, there is a dearth of knowledge concerning structure in a dynamic sense. The postulated conformational changes for lac permease are far too massive (3), and the subtle changes for the leucine transporter (96) and the H + /Cl − exchanger (97) are speculative. More evidence for the countertransporter behavior of ClC-ec1 is provided by the observation that when pH is varied symmetrically in asymmetric Cl − , it does not affect the reversal potential, whereas when pH is varied asymmetrically in symmetric Cl − , it does. To explain these data, one assumes that the reversal potential for the exchanger was
where r = m/n is the fixed H + /Cl − stoichiometry of countertransport, and E represents the Nernst potentials for Cl − or H + . This equation follows from the reaction
This formula predicts the measured reversal potentials better than the Goldman equation (98, 99) , which is written for a channel that is copermeable to Cl − and H + (see Supplemental Text, Section C4, and Supplemental Figure 4 ). However, Hodgkin & Horowicz in 1959 (100) wrote an expression for V rev that is identical to the above formula; the Hodgkin & Horowicz equation is, however, the reversal potential for a parallelbranch circuit used to model a membrane conductance (101) . In the transporter interpretation, r is a fixed ratio independent of voltage and ion concentration; in the channel interpretation, r is a conductance ratio and in general depends on voltage and concentrations. Thus, the channel interpretation of the Accardi & Miller data requires the H + /Cl − ratio to be fixed. The possibility remains that single-file conduction in a non-voltage-gated channel renders r approximately constant, and then calling the H + /Cl − exchanger an ion channel seems semantic.
Accardi & Miller show that a point mutation removes the proton dependence of the substrate flux, and causes ClC-ec1 to become purely Cl − selective. Curiously, however, this change creates a uniporter, not a channel. At a detailed molecular level, subtle molecular movements are likely involved. Thus, the difference between (a) a uniporter mediating the flux of one ion species and (b) an ion-selective channel is unclear. Examples like ClC-ec1 demonstrate that it may be exceedingly difficult to distinguish channels from transporters. For ion swapping at rates of 100 times per millisecond, as in ClC-ec1, there may not be much difference, aside from nomenclature, between the two mechanisms employed for ion/substrate flux.
A Proton Transporter Inside a K + Channel
The voltage sensitivity of K + channels arises from the presence of charged residues in the fourth TMD (S4) of each subunit in the tetrameric channel. When histidine (His) replaces all S4 charges except for the most extracellular arginine (Arg) (R362), S4 acts as a proton transporter (102) . Replacing R362 with His creates a proton pore when the channel is hyperpolarized. When His replaces the fourth S4 charge (R371H), both proton transport and conduction occur. However, proton conduction is small and occurs only at depolarized potentials (Figure 10) . The protein-bilayer interface is broken by aqueous crevices to allow proton access to R362H from both sides of the membrane (Figure 10e) . Operation of this proton pore revealed a unique structural feature of the voltage-sensing region, which has implications for naturally occurring voltage-dependent proton channels. In K + channels, S1-S4 functions as a self-contained voltage-sensing domain (VSD) that opens and closes the S5-S6 pore domain. A mammalian VSD protein, Hv1, which lacks a pore domain, exhibits voltage-sensitive, protonselective ion channel activity (103) . Mutagenesis of Hv1 identified three Arg residues in S4 that regulate gating. Hv1 is widely expressed in the immune system and belongs to a family of mammalian proton-conducting channels that straddles the border between channels and transporter proteins. 
Transporter Structure
Protein structure enters strongly into the Accardi-Miller argument because ClC-ec1 does not have an obvious channel motif, but then neither do homologous members of the CLC family, which are all thought to be authentic Cl − channels. The structures of channels and transporters, as far as they are known, are highly varied. The structures of enzymatic transporters, such as the Ca 2+ pump, are completely different from that of the proton-coupled lactose cotransporter (3, 106) . In turn, lac permease is structurally distinct from the Na + -coupled glutamate transporter (107) and the leucine transporter (96) . Furthermore, individual studies presenting structures for these transport proteins each evoke radically different mechanisms to achieve compliance with the traditional alternating access model. Lac permease ostensibly undergoes enormous conformational changes between outward-and inward-facing forms, whereas glutamate transport is envisaged as a complex of coordinated gates, like trap doors at the base of an immobile, membraneimbedded vestibule. Similarly, the structure of the leucine transporter gave rise to a hypothetical mechanism again involving a set of gates at the inner and outer faces, in line with previous suggestions for transporter mechanisms (51, 89) . Lac permease is a monomer, whereas the glutamate transporter is a trimer. A trimeric structure is also indicated for the ammonia channel (108), a molecule previously thought to be a proton-coupled transporter.
IMPLICATIONS

Synaptic Transmission
Half a century ago, Alan Hodgkin discovered the ionic basis of excitability, and Bernard Katz discovered the fundamentals of synaptic transmission (61) . The ability to generate action potentials, which in turn effect synaptic transmission, requires that Na + ions move across membranes down their electrochemical gradients. This drives action potentials to initiate neurotransmitter release and terminate the action of transmitters via Na +coupled reuptake mechanisms. Even the enzymatically degraded transmitter acetylcholine (ACh) relies on Na + -coupled choline uptake for its resynthesis (109) . Transporters located on presynaptic terminals, varicosities, and glial cells in the central nervous system rapidly and efficiently return neurotransmitters for repackaging and re-release. By this mechanism, transporters "time" the action of transmitters, localize transmitters to specific synapses, and recycle transmitters for reuse. Within the presynaptic terminal, proton-coupled transporters pack transmitters such as ACh, serotonin, and glutamate into synaptic vesicles.
Na + -coupled glutamate transporters representing one gene family, serotonin transporters representing another family, and choline transporters in yet another family have been cloned and characterized using multidisciplinary techniques. In addition, crystal structures of some transporters are becoming known, and these will contribute immensely to our understanding of transport mechanisms (110) . The main challenge remains to correlate molecular conformations with actual transport mechanisms. Despite new data, transmitter coupling to ion gradients looks roughly as it did 50 years ago (please see Supplemental Figure 2 ).
In the case of glutamate and monoamine transmitters, the evidence is overwhelming that large presynaptic currents accompany reuptake. Transporters thus return transmitter to the presynaptic cell and shape its physiology. It is difficult to accommodate these large currents, which in several cases are measured in actual neurons, with traditional models. For glutamate transporters, a syncretic model is proposed: Tight-coupling, fixed stoichiometry occurs in parallel with a Cl − channel imbedded in the transporter but not involved in glutamate transport. In the monoamine transporters, this does not appear to be the case. Serotonin, DA, and NE are themselves conducted through the transporter in its channel mode. Furthermore, the stoichiometry is not fixed but varies with voltage and both ionic and transmitter concentration. Moreover, in the monoamine transporters, authentic single-channel activity is observed in connection with transport. The conclusion seems inevitable that the molecular events underlying the large transporter currents are bonafide channel events.
If monoamine transporters are channels, how can they concentrate substrates? One proposed explanation is that presynaptic transporters never drive monoamines uphill, because an efficient packaging mechanism exists in synaptic vesicles. This begs to be questioned, however, because transmitter concentration inside vesicles itself requires cotransport. One may counter that no channel properties of vesicle transporters have been observed and thus there is no contradiction. However, whether or not the presynaptic membrane concentrates monoamines intracellularly, SERTs, NETs, and DATs can do the job under controlled situations.
We propose the following scenario. After transmitter is released, transporters near the release sites sense a huge gradient. Transmitter and Na + gate the transporter to open, and initially Na + rushes in, accounting for the initial spike in controlled conditions. Because of its greater affinity, the less-concentrated transmitter enters the pore and initially flows downhill. Stoichiometry thus changes with time and gradually adjusts from hundreds to several ions per transmitter but is never fixed. Under conditions in which the transporter does concentrate transmitter, single-file electrodiffusion comes into play, which allows coupled transport in a channel mode (Supplemental Text, Sections A2 and C4, and Supplemental Figure 3) .
A certain role of large inward transporter currents is membrane depolarization, which affects the excitability of the releasing neuron. Antidepressants and other drugs that block reuptake, whose actions are generally regarded as postsynaptic, may in addition have early and forceful presynaptic effects owing to blocked currents.
Cardiac Excitability
The case for channels in transporters is solid for neurotransmitter transporters, and in a few cases possible functions have been identified. This is less true for exchangers, such as the NCX, the anion exchanger (Band III), the Cl − /H + exchanger, and the Na + /K + /Cl − transporters. Nevertheless, in these cases, too, the observed currents are larger than one might expect from a purely carrier perspective and are in fact clearly comparable to channels. Unfortunately, however, no transporter channels in these exchangers have been directly observed.
Metal Ion Metabolism
The uncoupled flux of molecules may introduce into a transport system some degree of elasticity and hence adaptability. In this case, the overall processes to which the transport events contribute and the cells that express these transport systems may adjust constantly in relation to the environment. The uncoupled flux of molecules involved in cotransport processes has been referred to as a molecular slip mechanism. However, in the examples above as well as in other studies, experiments have shown that such uncoupled molecular flux exhibits channel-like properties in terms of ion conductance. Despite the growing evidence for the existence of uncoupled flux mechanisms or channels in transporters, the biological function of these currents remains unclear. This type of mechanism may provide a kind of buffering action or built-in autoregulatory role distinct from other modes of regulation. It may help maintain stability and contribute to homeostasis in cells, despite sometimes abrupt changes in the concentration of substrates or of other influencing conditions in the environment. According to Nelson and colleagues (111) , uncoupled flux mechanisms in transporters may serve a general protective role for the cell.
CONCLUSIONS
Regardless of whether uncoupled currents have a true biological purpose, the existence of channels in transporters has implications for the therapeutic modulations of these molecules. Channel mechanisms generally are better understood than the detailed workings of transporter function, a fact brought to light by the studies discussed in this review. The modulation of channel activities in transporter molecules may thus provide an alternative therapeutic route to alleviate transporter-associated disease conditions. We can perhaps look forward to a new genre of classification in which transporter molecules are no longer dichotomized into the rigid and classically opposing houses of channels and transporters but are treated with a more relaxed and unifying nomenclature that will re-flect more closely and comprehensively the true functional properties of these extraordinary multifunctional molecules.
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